Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

It might be a PR decision to encourage the name to hide the fact Gilead "Profited by Slow-Walking a Promising HIV Therapy". Profit before health.

https://www.nytimes.com/2023/07/22/business/gilead-hiv-drug-...



“For most people, experts say, the two tenofovir-based drugs — the first known as T.D.F., the second called T.A.F. — offer roughly equal risks and benefits.”

Do we have an update on the case?




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: